Search Results - "Le, L.W"

Does Early Tumor Regression Observed on Cone Beam Computed Tomography During Chemoradiation Therapy Predict Favorable Outcome in Locally Advanced Lung Adenocarcinoma? by Lin, A, Bezjak, A, Lim, G.W, Le, L.W, Higgins, J, Bissonnette, J.P, Sun, A

Get full text

Patterns of Failure in Anaplastic and Differentiated Thyroid Carcinomas Treated With External Beam Radiation Therapy by Vulpe, H, Kwan, J, McNiven, A.L, Brierley, J, Tsang, R.W, Chan, B, Goldstein, D, Le, L.W, Hope, A.J, Giuliani, M.E

Get full text

Prognostic Value of Pretreatment Neutrophil-Lymphocytes Ratio on Outcomes in Lung SBRT by Giuliani, M.E, Wong, O, Gay, J, Le, L.W, Cho, J, Brade, A.M, Sun, A, Bezjak, A, Hope, A.J

Get full text

Adaptive Dose Escalation using Serial Four-dimensional Positron Emission Tomography/Computed Tomography Scans during Radiotherapy for Locally Advanced Non-small Cell Lung Cancer by Yap, M.L, Sun, A, Higgins, J, Clarke, K, Marshall, A, Becker, N, Le, L.W, Vines, D.C, Bezjak, A, Bissonnette, J.-P

“…Abstract Aims Computed tomography (CT)-based radiotherapy dose escalation for locally advanced non-small cell lung cancer (LA-NSCLC) has had limited success…”
Get full text

Outcomes in Patients With Stage III Non-Small Cell Lung Cancer Treated With Neoadjuvant Concurrent Chemotherapy and Radiation Therapy Followed by Surgical Resection by Yau, V, Giuliani, M.E, Wong, O, Le, L.W, Darling, G, Shepherd, F, Brade, A.M, Cho, J, Sun, A, Bezjak, A, Hope, A.J

Get full text

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy by Giuliani, M, Sampson, L R, Wong, O, Gay, J, Le, L W, Cho, B C J, Brade, A, Sun, A, Bezjak, A, Hope, A J

“…In the present study, we determined the association of pretreatment circulating neutrophils, monocytes, and lymphocytes with clinical outcomes after lung…”
Get full text

Impact of Pretreatment Growth Rate on Outcome of Stage I Non-small Cell Lung Cancer After Stereotactic Body Radiation Therapy by Atallah, S, Bezjak, A, Taremi, M, Allibhai, Z, Le, L.W, Sun, A, Anthony, B, Cho, J, Hope, A

Get full text

Clinical Outcomes In Stage I Non-small Cell Lung Cancer Patients Managed With Accelerated Hypofractionated Radiotherapy by Giuliani, M.E, Yung, T, Le, L.W, Sun, A, Cho, J, Bezjak, A, Brade, A, Hope, A.J

Get full text

Postoperative IMRT following Surgery for Oral Cavity Squamous Cell Carcinoma: Patterns of Failure by Chan, A.K, Huang, S, Le, L.W, Goldstein, D.P, Chan, K, Dawson, L.A, Kim, J, O'Sullivan, B, Cummings, B, Hope, A.J

Get full text

Limited Stage Mantle Cell Lymphoma: Treatment Outcomes at the Princess Margaret Hospital by Tsang, R.W, Bernard, M, Le, L.W, Hodgson, D.C, Sun, A, Wells, W, Crump, M, Gospodarowicz, M.K

Get full text

Patterns of Failure in Patients with Limited-Stage Small Cell Lung Carcinoma by Giuliani, M.E, Lindsay, P.E, Sun, A, Bezjak, A, Le, L.W, Brade, A, Cho, J, Leighl, N, Shepherd, F.A, Hope, A.J

Get full text

Positron Emission Tomography for Response Assessment of Lymphoma Patients Having Residual Abnormalities following Initial Treatment: The Impact on Clinical Management by Bernard, M, Tsang, R.W, Le, L.W, Hodgson, D.C, Kuruvilla, J, Kukreti, V, Sun, A, Wells, W, Crump, M, Gospodarowicz, M.K

Get full text

IMRT and Concurrent Chemotherapy for Anal and Perianal Cancer: The Princess Margaret Hospital Experience by Han, K, Skliarenko, J, Craig, T, Le, L.W, Cummings, B.J, Brierley, J.D, Wong, R.K, Krzyzanowska, M.K, Chen, E.X, Kim, J.J

Get full text

IMRT for Oropharyngeal Squamous Cell Carcinoma (OSCC): Analysis of Dosimetry and Patterns of Failure by Nikapota, A.D, Cummings, B.J, O'Sullivan, B, Waldron, J.N, Dawson, L.A, Ringash, J, Le, L.W, Breen, S.L, Yu, E, Kim, J.J

Get full text

Undertaking Longitudinal Research Studies with Cancer Survivors: Can These Studies Succeed Long-Term? by Koh, E, Hodgson, D.C, Nyhof-Young, J, Milosevic, M, Le, L.W, Lau, A, Catton, P.A

Get full text

Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer by Lim, C., Tsao, M.S., Le, L.W., Shepherd, F.A., Feld, R., Burkes, R.L., Liu, G., Kamel-Reid, S., Hwang, D., Tanguay, J., da Cunha Santos, G., Leighl, N.B.

“…Testing for EGFR mutations and ALK rearrangement has become standard in managing advanced nonsmall-cell lung cancer (NSCLC). However, many institutions in…”
Get full text

Impact of early palliative care on caregivers of patients with advanced cancer: cluster randomised trial by McDonald, J., Swami, N., Hannon, B., Lo, C., Pope, A., Oza, A., Leighl, N., Krzyzanowska, M.K., Rodin, G., Le, L.W., Zimmermann, C.

“…Early palliative care improves the quality of life (QoL) and satisfaction with care of patients with advanced cancer, but little is known about its effect on…”
Get full text

Esophageal Toxicity in Thoracic Stereotactic Radiation Therapy by Yau, V., Lindsay, P.E., Hope, A.J., Le, L.W., Glick, D., Lau, A., Cho, J., Bezjak, A., Sun, A., Giuliani, M.E.

Get full text

Factors associated with length of stay in an acute palliative care unit: A retrospective analysis by Hausner, D., Pope, A., Kevork, N., Le, L.W., Zimmermann, C.

Get full text

A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer by Fung, A.S., Graham, D.M., Chen, E.X., Stockley, T.L., Zhang, T., Le, L.W., Albaba, H., Pisters, K.M., Bradbury, P.A., Trinkaus, M., Chan, M., Arif, S., Zurawska, U., Rothenstein, J., Zawisza, D., Effendi, S., Gill, S., Sawczak, M., Law, J.H., Leighl, N.B.

“…•Recommended phase II dose is binimetinib 30 mg BID with carboplatin/pemetrexed in non-squamous NSCLC.•Manageable toxicities observed with the combination of…”
Get full text